You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MK2 inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolaemia Trial (MK-0616)

Not yet recruiting
  • Hypercholesterolaemia
  • (no location specified)
Jul 12, 2023

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 14, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • +2 more
  • Indianapolis, Indiana
  • +8 more
May 5, 2023

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Stage IV Renal Cell Cancer AJCC V7 Trial in Calgary, Toronto (Pembrolizumab, Stereotactic Body Radiation Therapy)

Completed
  • Stage IV Renal Cell Cancer AJCC V7
  • Calgary, Alberta, Canada
  • +2 more
Aug 26, 2021

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Duarte, California
  • +8 more
Mar 15, 2022

Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Arteriosclerosis
  • Hypercholesterolaemia
  • (no location specified)
Aug 17, 2023

Endometrial Cancer Trial in Canada (Niraparib, TSR-042)

Active, not recruiting
  • Endometrial Cancer
  • Calgary, Alberta, Canada
  • +6 more
Nov 18, 2021

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Brain Metastases Trial in Houston (Niraparib, Dostarlimab)

Not yet recruiting
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

Terminated
Has Results
  • AML Including AML de Novo and AML Secondary to MDS
  • DLBCL
  • Birabresib Dose 20 mg
  • (no location specified)
Aug 23, 2022